A phase I dose-escalation study of the MDM2-p53 antagonist BI 907828 in patients (pts) with advanced solid tumors Meeting Abstract
| Authors: | LoRusso, P.; Gounder, M. M.; Patel, M. R.; Yamamoto, N.; Bauer, T. M.; Laurie, S.; Grempler, R.; Davenport, T.; Geng, J.; Rohrbacher, M.; Lahmar, M. |
| Abstract Title: | A phase I dose-escalation study of the MDM2-p53 antagonist BI 907828 in patients (pts) with advanced solid tumors |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120601193 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.3016 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3016 -- Source: Wos |
